We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bayer AG | TG:BAYN | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.31 | 4.80% | 28.625 | 28.635 | 28.645 | 28.775 | 27.815 | 27.88 | 182,574 | 08:33:30 |
From May 2021 to May 2024
By Cecilia Butini
Bayer AG said Wednesday that research-and-development investments in its agricultural business is expected to fuel mid- and long-term growth at the company, with the potential for the business to bring in up to 30 billion euros ($34.08 billion) over the next two decades.
The German pharmaceutical-and-agricultural company also said a technology it developed to improve corn farming, which it has named Short Stature Corn, is expected to generate an incremental peak sales opportunity of about EUR1 billion in North America.
Bayer is advancing in its development of seeds and products for crop protection, and is having pest-control and fungicides products progress to next development phases, it said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
February 16, 2022 08:20 ET (13:20 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
